title: Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cells.
abstract: The differentiation-inducing activity of doxorubicin on B16 melanoma cells grown in vitro was compared with that of other known differentiation inducers, such as theophylline, retinoic acid, and melanocyte-stimulating hormone (MSH). At drug concentrations resulting in cytostatic effects, doxorubicin and theophylline induced morphological changes (dendritic-like structures with a terminal melanin granule) with an enhancement of total melanin content and tyrosinase activity. Retinoic acid did not alter melanin content and cell morphology, although it affected cell growth. MSH enhanced total melanin content and tyrosinase activity, with no significant morphological changes. Flow cytometric analysis showed that MSH led to an accumulation of cells in G1 phase whereas doxorubicin induced an accumulation of cells in G2 + M. Studies on DNA content in doxorubicin-treated cells, selected on the basis of a morphologically differentiated pattern, showed a clustering of these cells in G2 + M, probably due to a cytokinesis block. Thus doxorubicin can induce cell differentiation comparable with other differentiation inducers.
authors.affiliation: Istituto Nazionale Tumori, Milan, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Supino
authors.forename: M
authors.initials: M
authors.lastname: Mariani
authors.forename: A
authors.initials: A
authors.lastname: Colombo
authors.forename: E
authors.initials: E
authors.lastname: Prosperi
authors.forename: A C
authors.initials: AC
authors.lastname: Croce
authors.forename: G
authors.initials: G
authors.lastname: Bottiroli
mesh_terms: D000818:Animals; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D004273:DNA, Neoplasm / Q000032:analysis; D004317:Doxorubicin / Q000494:pharmacology*; D005110:Extracellular Space / Q000737:chemistry; D007424:Intracellular Fluid / Q000737:chemistry; D008543:Melanins / Q000032:analysis; D008546:Melanoma, Experimental / Q000188:drug therapy* / Q000473:pathology; D014442:Monophenol Monooxygenase / Q000378:metabolism; D013806:Theophylline / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured; D000521:alpha-MSH / Q000494:pharmacology
chemical_list: D004273:DNA, Neoplasm; D008543:Melanins; D014212:Tretinoin; D000521:alpha-MSH; D004317:Doxorubicin; D013806:Theophylline; D014442:Monophenol Monooxygenase